Macrogenics (MGNX) Cash from Investing Activities (2012 - 2026)

Macrogenics (MGNX) has reported Cash from Investing Activities for 15 consecutive years, with $45.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 357.67% year-over-year to $45.3 million; the TTM figure through Mar 2026 stood at -$78.7 million (down 158.54% YoY), while the FY2025 annual figure was -$114.1 million, down 176.42% from the prior year.
• Cash from Investing Activities rose to $45.3 million in Q1 2026 per MGNX's latest filing, from -$66.0 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $71.9 million in Q3 2022 and bottomed at -$113.5 million in Q2 2023.
• Historically, Cash from Investing Activities has averaged $4.2 million across 5 years, with a median of $23.0 million in 2022.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities surged 2849.18% — and 2023, when it slumped 592.54%.
• Macrogenics' Cash from Investing Activities stood at -$5.8 million in 2022, then soared by 770.73% to $38.8 million in 2023, then grew by 6.81% to $41.5 million in 2024, then slumped by 259.14% to -$66.0 million in 2025, then jumped by 168.67% to $45.3 million in 2026.
• Business Quant data shows MGNX's Cash from Investing Activities at $45.3 million in Q1 2026, -$66.0 million in Q4 2025, and -$20.4 million in Q3 2025.